PFE - Pfizer Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue52,546,00052,824,00048,851,000
Cost of Revenue11,240,00012,329,0009,648,000
Gross Profit41,306,00040,495,00039,203,000
Operating Expenses
Research Development7,657,0007,872,0007,690,000
Selling General and Administrative14,784,00014,837,00014,809,000
Non Recurring487,0001,724,0001,152,000
Others4,758,0004,056,0003,728,000
Total Operating Expenses27,686,00028,489,00027,379,000
Operating Income or Loss13,620,00012,006,00011,824,000
Income from Continuing Operations
Total Other Income/Expenses Net-1,315,000-3,655,000-2,860,000
Earnings Before Interest and Taxes12,305,0008,351,0008,965,000
Interest Expense---
Income Before Tax12,305,0008,351,0008,965,000
Income Tax Expense-9,049,0001,123,0001,990,000
Minority Interest348,000296,000278,000
Net Income From Continuing Ops21,353,0007,229,0006,975,000
Non-recurring Events
Discontinued Operations2,00017,00011,000
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income21,308,0007,215,0006,960,000
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares21,308,0007,215,0006,960,000